These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22334793)

  • 1. The immunomodulatory effect of inhaled granulocyte-macrophage colony-stimulating factor in cystic fibrosis. A new treatment paradigm.
    Heslet L; Bay C; Nepper-Christensen S
    J Inflamm Res; 2012; 5():19-27. PubMed ID: 22334793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses.
    Sheng G; Chen P; Wei Y; Chu J; Cao X; Zhang HL
    Respir Res; 2018 Aug; 19(1):163. PubMed ID: 30165864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage tumor necrosis factor-alpha induces epithelial expression of granulocyte-macrophage colony-stimulating factor: impact on alveolar epithelial repair.
    Cakarova L; Marsh LM; Wilhelm J; Mayer K; Grimminger F; Seeger W; Lohmeyer J; Herold S
    Am J Respir Crit Care Med; 2009 Sep; 180(6):521-32. PubMed ID: 19590023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24 months of follow-up.
    Tian X; Yang Y; Chen L; Sui X; Xu W; Li X; Guo X; Liu L; Situ Y; Wang J; Zhao Y; Meng S; Song W; Xiao Y; Xu KF
    Orphanet J Rare Dis; 2020 Jul; 15(1):174. PubMed ID: 32615994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of GM-CSF and G-CSF correlate with the Th1/Th2 cytokine response in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.
    Moser C; Jensen PØ; Pressler T; Frederiksen B; Lanng S; Kharazmi A; Koch C; Høiby N
    APMIS; 2005 Jun; 113(6):400-9. PubMed ID: 15996157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute radiation syndrome (ARS) - treatment of the reduced host defense.
    Heslet L; Bay C; Nepper-Christensen S
    Int J Gen Med; 2012; 5():105-15. PubMed ID: 22319248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical role of alveolar macrophage-derived granulocyte-macrophage colony-stimulating factor in pulmonary host defense post-bone marrow transplantation.
    Ballinger MN; Hubbard LL; McMillan TR; Toews GB; Peters-Golden M; Paine R; Moore BB
    Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L114-22. PubMed ID: 18456799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.
    Tazawa R; Nakata K; Inoue Y; Nukiwa T
    Respirology; 2006 Jan; 11 Suppl():S61-4. PubMed ID: 16423274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation.
    Agostini C; Trentin L; Zambello R; Bulian P; Caenazzo C; Cipriani A; Cadrobbi P; Garbisa S; Semenzato G
    J Immunol; 1992 Nov; 149(10):3379-85. PubMed ID: 1431112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-macrophage colony stimulatory factor enhances the pro-inflammatory response of interferon-γ-treated macrophages to Pseudomonas aeruginosa infection.
    Singh S; Barr H; Liu YC; Robins A; Heeb S; Williams P; Fogarty A; Cámara M; Martínez-Pomares L
    PLoS One; 2015; 10(2):e0117447. PubMed ID: 25706389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.
    Tazawa R; Ueda T; Abe M; Tatsumi K; Eda R; Kondoh S; Morimoto K; Tanaka T; Yamaguchi E; Takahashi A; Oda M; Ishii H; Izumi S; Sugiyama H; Nakagawa A; Tomii K; Suzuki M; Konno S; Ohkouchi S; Tode N; Handa T; Hirai T; Inoue Y; Arai T; Asakawa K; Sakagami T; Hashimoto A; Tanaka T; Takada T; Mikami A; Kitamura N; Nakata K
    N Engl J Med; 2019 Sep; 381(10):923-932. PubMed ID: 31483963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Signaling of granulocyte macrophage colony stimulating factor and its clinical application: host-defense and organ protection].
    Uchida K
    Masui; 2013 Mar; 62(3):265-74. PubMed ID: 23544327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice.
    Zsengellér ZK; Reed JA; Bachurski CJ; LeVine AM; Forry-Schaudies S; Hirsch R; Whitsett JA
    Hum Gene Ther; 1998 Sep; 9(14):2101-9. PubMed ID: 9759936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages.
    Wu H; Suzuki T; Carey B; Trapnell BC; McCormack FX
    J Biol Chem; 2011 Apr; 286(17):14932-40. PubMed ID: 21343299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R
    Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Response to inhaled granulocyte-macrophage colony-stimulating factor in a patient with alveolar proteinosis].
    Rodríguez Portal JA; Rodríguez Becerra E; Sánchez Garrido A
    Arch Bronconeumol; 2009 Mar; 45(3):150-2. PubMed ID: 19286115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosis.
    Seymour JF; Begley CG; Dirksen U; Presneill JJ; Nicola NA; Moore PE; Schoch OD; van Asperen P; Roth B; Burdach S; Dunn AR
    Blood; 1998 Oct; 92(8):2657-67. PubMed ID: 9763547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
    Tazawa R; Hamano E; Arai T; Ohta H; Ishimoto O; Uchida K; Watanabe M; Saito J; Takeshita M; Hirabayashi Y; Ishige I; Eishi Y; Hagiwara K; Ebina M; Inoue Y; Nakata K; Nukiwa T
    Am J Respir Crit Care Med; 2005 May; 171(10):1142-9. PubMed ID: 15735059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
    Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extra-pulmonary aspects of acquired pulmonary alveolar proteinosis as predicted by granulocyte-macrophage colony-stimulating factor-deficient mice.
    Seymour JF
    Respirology; 2006 Jan; 11 Suppl():S16-22. PubMed ID: 16423263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.